✦ LIBER ✦

Cardiotoxicity associated with trastuzumab treatment of HER2+ breast cancer

✍ Scribed by Manuela Fiúza

Publisher: Springer Healthcare Communications
Year: 2009
Tongue: English
Weight: 542 KB
Volume: 26
Category: Article
ISSN: 0741-238X
DOI: 10.1007/s12325-009-0048-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Population pharmacokinetics of trastuzum

Population pharmacokinetics of trastuzumab in patients With HER2+ metastatic breast cancer

✍ Rene Bruno; Carla B. Washington; Jian-Feng Lu; Grazyna Lieberman; Ludger Banken; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 354 KB

Anthracycline cardiotoxicity in breast c

Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes

✍ Luca Gianni; Emanuela Salvatorelli; Giorgio Minotti 📂 Article 📅 2007 🏛 Humana Press Inc 🌐 English ⚖ 199 KB

Trastuzumab-based neoadjuvant therapy in

Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer

✍ Helena R. Chang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB 👁 2 views

Role of trastuzumab in patients with bra

Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer

✍ Nilufer Bulut; Hakan Harputluoglu; Omer Dizdar; Kadri Altundag 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 84 KB

Recent trends of HER-2 testing and trast

Recent trends of HER-2 testing and trastuzumab therapy for breast cancer

✍ Masafumi Kurosumi 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 279 KB

Cost-effectiveness analysis of trastuzum

Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer

✍ Louis P. Garrison Jr; Deborah Lubeck; Deepa Lalla; Virginia Paton; Amylou Dueck; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

## Abstract ## BACKGROUND. Adding trastuzumab to adjuvant chemotherapy provides significant clinical benefit in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. A cost‐effectiveness analysis was performed to assess clinical and economic implications of adding t